KIMMTRAK conc perf 100 mcg/0.5 ml flac

7680688460018 CH-68846 L01XX75 07.16.1.

Reimbursement limitations:

KIMMTRAK.01

La thérapie avec KIMMTRAK nécessite une garantie de prise en charge par l’assureur-maladie après consultation …

KIMMTRAK conc perf 100 mcg/0.5 ml flac
KIMMTRAK conc perf 100 mcg/0.5 ml flac
KIMMTRAK conc perf 100 mcg/0.5 ml flac
1 / 3
google

Details

Product number
6884601
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
tebentafuspum 0.10 mg, acidum citricum monohydricum, dinatrii phosphas dodecahydricus, mannitolum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp. natrium 0.94 mg.

Articles (1)

Kimmtrak 100 mcg / 0.5 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
31/03/2025
Professional SmPC
Français
31/03/2025
Professional SmPC
Italien
31/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.1 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.94 MG Substance HBESI

Reimbursement information

Public price
CHF 12072.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2024

Authorization holder

Immunocore GmbH

6343 Risch

Authorization information

Swissmedic authorization number
68846
Drug name
Kimmtrak, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01XX75
Authorization status
Z
Dispensation category
A
First authorization
09/05/2023
Authorization expiration date
08/05/2028
IT number
07.16.1.
Domain
Human medicine
Field of application
Uveales Melanom

Packaging details

Description (FR)
KIMMTRAK conc perf 100 mcg/0.5 ml flac
Description (DE)
KIMMTRAK Inf Konz 100 mcg/0.5 ml Durchstf
Market launch
09/05/2023
Narcotic (BTM)
No